Cargando…
Reporting reimbursement price decisions for onco-hematology drugs in Spain
INTRODUCTION: Even using well-established technology assessment processes, the basis of the decisions on drug price and reimbursement are sometimes perceived as poorly informed and sometimes may be seen as disconnected from value. The literature remains inconclusive about how Health Technology Asses...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627880/ https://www.ncbi.nlm.nih.gov/pubmed/37942255 http://dx.doi.org/10.3389/fpubh.2023.1265323 |